Back to FMR LLC FMR LLC

VKTX

Showing 8 of 28 quarters

Position history for FMR LLCFMR LLC's holdings in Viking Therapeutics, Inc.

Yes. FMR holds 6,335,756 shares of VKTX (Viking Therapeutics), worth $247.2M, as of its Q2 2026 13F filing. It increased the position by 311,003 shares (+5.2%) from Q1 2026. FMR has held VKTX in every 13F on record since Q3 2019, 28 quarterly filings.

Current Value

$247.2M

Current Shares

6.3M

Total Value Change

-$805M

Total Shares Change

-10.3M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
6.3M
+5.2%
$247.2M0.0%$39.01
32
2026-Q1
Decreased
6M
-8.1%
$196M0.0%$32.54
0
2025-Q4
Increased
6.6M
+13.3%
$230.7M0.0%$35.18
35
2025-Q3
Decreased
5.8M
-41.0%
$152.2M0.0%$26.28
0
2025-Q2
Decreased
9.8M
-12.7%
$260.3M0.0%$26.50
0
2025-Q1
Decreased
11.2M
-32.7%
$271.7M0.0%$24.15
0
2024-Q4
Increased
16.7M
+0.6%
$672.6M0.0%$40.24
32
2024-Q3
Increased
16.6M
+0.5%
$1.1B0.1%$63.31
32

Other major holders of VKTX: BlackRock Finance, Inc., Vanguard Group Inc., BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used